Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy.

Authors:
Guey S; Hervé D; Kossorotoff M; Ha G; Aloui C and 10 more

Journal:
Hum Genomics

Publication Year: 2023

DOI:
10.1186/s40246-023-00471-x

PMCID:
PMC10026487

PMID:
36941667

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Hum Genomics

Abbreviation: Hum Genomics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A broad wastewater screening and clinical data surveillance for virus-related diseases in the metro…
Li Y; Miyani B; Faust RA and 2 more (2024) - Transparency Score: 3/6
A novel upregulated hsa_circ_0032746 regulates the oncogenesis of esophageal squamous cell carcinom…
Shrestha SM; Fang X; Ye H and 3 more (2024) - Transparency Score: 4/6
Mutations in TSPAN12 gene causing familial exudative vitreoretinopathy.
Ju Y; Chen T; Ruan L and 3 more (2024) - Transparency Score: 3/6
Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity.
Kiiski JI; Neuvonen M; Kurkela M and 10 more (2024) - Transparency Score: 3/6
Wastewater-based epidemiology applied at the building-level reveals distinct virome profiles based …
Mejías-Molina C; Pico-Tomàs A; Martínez-Puchol S and 7 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Informed consentAll included probands and family members provided their written informed consent for genetic analysis as requested by the French law, and for publication of data. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This study has been supported by INSERM, the Leducq foundation (Transatlantic Network of excellence grant “ReVAMP-Recalibrating Mechanotransduction in Vascular Malformations 2022–2027") and the French Tanguy Moyamoya Disease patient’s association. Dr Guey was a recipient of Fondation pour la Recherche Médicale PhD fellowship."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025